- Type / Class
- Equity / Common Stock
- Shares outstanding
- 47,953,549
- Total 13F shares
- 49,891,551
- Share change
- +2,212,725
- Total reported value
- $1,074,666,783
- Price per share
- $21.54
- Number of holders
- 193
- Value change
- +$46,085,035
- Number of buys
- 110
- Number of sells
- 76
Quarterly Holders Quick Answers
What is CUSIP 09062W204?
CUSIP 09062W204 identifies BLFS - BIOLIFE SOLUTIONS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062W204:
Top shareholders of BLFS - BIOLIFE SOLUTIONS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Casdin Capital, LLC |
13F
|
Company |
18%
|
8,707,165
|
$198,871,649 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
11%
|
5,472,493
|
$124,991,740 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
7.4%
|
3,551,054
|
$81,106,073 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
2,804,140
|
$64,046,557 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.1%
|
536,297
|
$37,244,811 | — | 31 Mar 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
3.2%
|
1,533,122
|
$35,016,506 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
1,433,796
|
$32,747,901 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.8%
|
1,348,008
|
$30,789,000 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2%
|
970,412
|
$22,164,209 | — | 31 Mar 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
2%
|
964,257
|
$22,023,630 | — | 31 Mar 2025 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2%
|
947,085
|
$21,631,421 | — | 31 Mar 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2%
|
946,623
|
$21,620,869 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
920,273
|
$21,029,452 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
1.9%
|
897,421
|
$20,497,092 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
887,256
|
$20,269,663 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.8%
|
860,744
|
$19,659,393 | — | 31 Mar 2025 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
852,127
|
$19,462,578 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.6%
|
764,671
|
$17,465,086 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
1.5%
|
698,251
|
$15,948,000 | — | 31 Mar 2025 | |
| CRAMER ROSENTHAL MCGLYNN LLC |
13F
|
Company |
1.4%
|
684,385
|
$15,631,353 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.2%
|
584,504
|
$13,350,071 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
574,377
|
$13,118,770 | — | 31 Mar 2025 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
1.1%
|
540,952
|
$12,355,344 | — | 31 Mar 2025 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
522,410
|
$11,931,844 | — | 31 Mar 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1%
|
497,231
|
$11,356,756 | — | 31 Mar 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.92%
|
439,500
|
$10,038,180 | — | 31 Mar 2025 | |
| Curi Capital, LLC |
13F
|
Company |
0.91%
|
438,685
|
$10,019,560 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.87%
|
417,936
|
$9,545,668 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
405,807
|
$9,268,632 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.81%
|
388,504
|
$8,873,431 | — | 31 Mar 2025 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
364,446
|
$8,323,947 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.72%
|
345,548
|
$7,892,321 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.71%
|
340,826
|
$7,784,466 | — | 31 Mar 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
0.7%
|
336,840
|
$7,693,426 | — | 31 Mar 2025 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.65%
|
309,686
|
$7,073,228 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.62%
|
297,448
|
$6,793,712 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.6%
|
286,893
|
$6,552,636 | — | 31 Mar 2025 | |
| Gagnon Advisors, LLC |
13F
|
Company |
0.57%
|
274,217
|
$6,263,116 | — | 31 Mar 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.57%
|
273,329
|
$6,242,834 | — | 31 Mar 2025 | |
| Michael Rice |
3/4/5
|
Former CEO and Director |
—
class O/S missing
|
347,085
|
$5,938,624 | — | 30 Oct 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.54%
|
259,488
|
$5,926,706 | — | 31 Mar 2025 | |
| Uniplan Investment Counsel, Inc. |
13F
|
Company |
0.52%
|
247,378
|
$5,650,129 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.51%
|
243,278
|
$5,556,470 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.46%
|
221,789
|
$5,065,651 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.45%
|
216,554
|
$4,946,094 | — | 31 Mar 2025 | |
| Bard Financial Services, Inc. |
13F
|
Company |
0.32%
|
153,475
|
$3,505,369 | — | 31 Mar 2025 | |
| Meros Investment Management, LP |
13F
|
Company |
0.27%
|
131,650
|
$3,006,886 | — | 31 Mar 2025 | |
| ISTHMUS PARTNERS, LLC |
13F
|
Company |
0.27%
|
131,616
|
$3,006,109 | — | 31 Mar 2025 | |
| Garrie Richardson |
3/4/5
|
Chief Revenue Officer |
—
class O/S missing
|
114,773
|
$2,883,098 | — | 16 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
122,802
|
$2,804,798 | — | 31 Mar 2025 |
Institutional Holders of BIOLIFE SOLUTIONS INC - Common Stock (BLFS) as of Q2 2025
As of 30 Jun 2025,
BIOLIFE SOLUTIONS INC - Common Stock (BLFS) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,891,551 shares.
The largest 10 holders included
Casdin Capital, LLC, BlackRock, Inc., T. Rowe Price Investment Management, Inc., Invesco Ltd., VANGUARD GROUP INC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, AMERIPRISE FINANCIAL INC, and Rockefeller Capital Management L.P..
This page lists
192
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
188
Q2 2025 holders
193
Holder diff
5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.